Prospectus concerning Precise Biometrics' rights issue is published

Prospectus concerning Precise Biometrics' rights issue is published

The Board of Directors of Precise Biometrics has established a
prospectus concerning the forth­coming share issue with preferential
right for existing shareholders. The prospectus has been registered by
the Swedish Financial Supervisory Authority (SFA) and is available in
Swedish at
www.precisebiometrics.com/prospectus (http://www.precisebiometrics.com/p
rospectus)  and www.remium.com (http://www.remium.com/).

The prospectus in Swedish can also be received free of charge from
Precise Biometrics, Scheelevägen 30, Box 798, 220 07 Lund, Sweden, tel.
+46 (0) 46-46 31 11 34 or from Remium AB, Kungsgatan 12-14, 111 35
Stockholm, Sweden tel. +46 (0)8-454 32 00.
For information in English, we refer to Precise Biometrics and Remium.

Important information
The publication or distribution of this press release may in certain
jurisdictions be subject to restriction by law, and persons in the
jurisdictions where this press release has been published or distributed
should inform themselves of and follow such legal restrictions.

This press release may not be made public, published or distributed,
either directly or indirectly in the United States, Canada, Japan, New
Zealand, South Africa, Australia or any other country where such
procedures are subject in full or in part to legal restrictions. Nor may
the information in this press release may not be communicated,
reproduced or presented in any way that is in conflict with such
restrictions. Failure to follow this instruction may involve a breach of
the United States Securities Act from 1933 ("Securities Act") or
applicable laws in other jurisdictions.

In any EEA Member State that has implemented Directive 2003/71/EC
(together with any applicable implementing measures in any Member State,
the “Prospectus Directive”) other than Sweden, Denmark and the United
Kingdom, this press release is only addressed to and is only directed at
qualified investors in that Member State within the meaning of the
Prospectus Directive (or are other persons to whom a public offering of
securities may lawfully be addressed under the Prospectus Directive).

This press release does not contain or constitute an invitation or offer
to acquire, subscribe to or otherwise trade with shares, subscription
rights or other securities in Precise Biometrics. The invitation to the
persons concerned to subscribe to shares in Precise Biometrics will only
take place through the Prospectus that Precise Biometrics publishes
through this press release, and the Prospectus contains financial
statements and other information on Precise Biometrics' board of
directors and auditors.

Neither the subscription rights, paid subscribed shares or the new
shares will be registered in accordance with the Securities Act or any
other act in Canada, and may not be transferred or offered for sale in
the United States or Canada, or to persons domiciled there, or on behalf
of such persons, other than in such exceptional cases where registering
in accordance with the Securities Act or other act in Canada is not
required.

This press release may contain forward-looking statements. When used in
this press release, words such as “evaluate”, “expect” and “intend” are
intended to identify forward-looking statements. They may involve risks
and uncertainties, including product demand and market acceptance, the
effect of economic conditions, the impact of competitive products and
pricing, foreign currency exchange rates and other risks. These
forward-looking statements reflect the views of the management as of the
date made with respect to future events and are subject to risks and
uncertainties. All of these forward-looking statements are based on
estimates and assumptions made by the management and are believed to be
reasonable, though are inherently uncertain and difficult to predict.
Actual results or experience could differ materially from the
forward-looking statements. Precise Biometrics disclaims any intention
or obligation to update these forward-looking statements.

This press release consists of such information that Precise Biometrics
AB may be obliged to disclose in accordance with the Swedish Securities
Market Act and /or the Financial Instruments Trading Act. The
information was submitted for publication on May 3, 2011 at 3:45 p.m
CET.

For more information
Thomas Marschall, President and CEO, Precise Biometrics AB
Tel. 46 (0)46 31 11 10 or 46 (0) 734 35 11 10
E-mail
thomas.marschall@precisebiometrics.com (thomas.marschall@precisebiometri
cs.com)
Patrik Norberg, CFO, Precise Biometrics AB
Tel. 46 (0)46 31 11 47 or 46 (0) 734 35 11 47
E-mail
patrik.norberg@precisebiometrics.com (patrik.norberg@precisebiometrics.c
om)